Fig. 2

The levels of serum 8-iso-PGF2α in control subjects and CAP patients. a-f Serum S100A9 was detected with ELISA. a The level of serum S100A9 in CAP patients and No-CAP cases. b The level of serum S100A9 in different grades of CRB-65 score in CAP patients. c The level of serum S100A9 in different grades of SMART-COP score in CAP patients. d The level of serum S100A9 in different grades of CURXO score in patients with CAP. e The level of serum S100A9 in different grades of SMART-COP score in CAP patients. f The level of serum S100A9 in different grades of PSI score in CAP patients. All data were expressed as mean ± SEM. *P<0.05, **P<0.01